Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Carpiniello, Bernardo
Baita, Antonella
Carta, Mauro Giovanni
Sitzia, Rossella
Macciardi, Adolfo María
Murgia, Stefano
and
Altamura, Alfredo Carlo
2003.
Evolución clínica y psicosocial de los pacientes afectados por trastorno de angustia con o sin agorafobia: resultados de un estudio de seguimiento naturalista.
European psychiatry (Ed. Española),
Vol. 10,
Issue. 4,
p.
228.
Monkul, E. Serap
Tural, �mit
Onur, Elif
Fidaner, H�ray
Alk?n, Tun�
and
Shear, M. Katherine
2004.
Panic Disorder Severity Scale: Reliability and validity of the Turkish version.
Depression and Anxiety,
Vol. 20,
Issue. 1,
p.
8.
KIKUCHI, MITSURU
KOMURO, RYUTAROU
OKA, HIROSHI
KIDANI, TOMOKAZU
HANAOKA, AKIRA
and
KOSHINO, YOSHIFUMI
2005.
Panic disorder with and without agoraphobia: comorbidity within a half‐year of the onset of panic disorder.
Psychiatry and Clinical Neurosciences,
Vol. 59,
Issue. 6,
p.
639.
Bruce, Steven E.
Yonkers, Kimberly A.
Otto, Michael W.
Eisen, Jane L.
Weisberg, Risa B.
Pagano, Maria
Shea, M. Tracie
and
Keller, Martin B.
2005.
Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective Study.
American Journal of Psychiatry,
Vol. 162,
Issue. 6,
p.
1179.
Guo, Qinglong
Qi, Qi
You, Qidong
Gu, Hongyan
Zhao, Li
and
Wu, Zhaoqiu
2006.
Toxicological Studies of Gambogic Acid and its Potential Targets in Experimental Animals.
Basic & Clinical Pharmacology & Toxicology,
Vol. 99,
Issue. 2,
p.
178.
Yen, Cheng-Fang
Kuo, Chun-Ya
Tsai, Pei-Tzu
Ko, Chih-Hung
Yen, Ju-Yu
and
Chen, Tzu-Ting
2007.
Correlations of quality of life with adverse effects of medication, social support, course of illness, psychopathology, and demographic characteristics in patients with panic disorder.
Depression and Anxiety,
Vol. 24,
Issue. 8,
p.
563.
Gulsun, Murat
Doruk, Ali
Uzun, Ozcan
Turkbay, T??mer
and
Ozsahin, Aytekin
2007.
Effect of Dissociative Experiences on Drug Treatment of Panic Disorder.
Clinical Drug Investigation,
Vol. 27,
Issue. 8,
p.
583.
Bringager, Christine B.
Friis, Svein
Arnesen, Harald
and
Dammen, Toril
2008.
Nine-year follow-up of panic disorder in chest pain patients: clinical course and predictors of outcome.
General Hospital Psychiatry,
Vol. 30,
Issue. 2,
p.
138.
Bruce, Steven E.
Yonkers, Kimberly A.
Otto, Michael W.
Eisen, Jane L.
Weisberg, Risa B.
Pagano, Maria
Shea, M. Tracie
and
Keller, Martin B.
2008.
Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective Study.
Focus,
Vol. 6,
Issue. 4,
p.
539.
Schmidt, Norman B.
and
Cromer, Kiara R.
2008.
Assessing the clinical utility of agoraphobia in the context of panic disorder.
Depression and Anxiety,
Vol. 25,
Issue. 2,
p.
158.
Manfro, Gisele Gus
Heldt, Elizeth
Cordioli, Aristides Volpato
and
Otto, Michael W
2008.
Terapia cognitivo-comportamental no transtorno de pânico.
Revista Brasileira de Psiquiatria,
Vol. 30,
Issue. suppl 2,
p.
s81.
Bringager, Christine B.
Gauer, Katrine
Arnesen, Harald
Friis, Svein
and
Dammen, Toril
2008.
Nonfearful Panic Disorder in Chest-Pain Patients: Status After Nine-Year Follow-Up.
Psychosomatics,
Vol. 49,
Issue. 5,
p.
426.
Qi, Qi
Peng, Jian
Liu, Wei
You, Qidong
Yang, Yong
Lu, Na
Wang, Guangji
and
Guo, Qinglong
2009.
Toxicological studies of wogonin in experimental animals.
Phytotherapy Research,
Vol. 23,
Issue. 3,
p.
417.
Pirkola, Sami
Saarni, Samuli
Suvisaari, Jaana
Elovainio, Marko
Partonen, Timo
Aalto, Anna-Mari
Honkonen, Teija
Perälä, Jonna
and
Lönnqvist, Jouko
2009.
General health and quality-of-life measures in active, recent, and comorbid mental disorders: a population-based health 2000 study.
Comprehensive Psychiatry,
Vol. 50,
Issue. 2,
p.
108.
Ramsawh, H. J.
Raffa, S. D.
Edelen, M. Orlando
Rende, R.
and
Keller, M. B.
2009.
Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder.
Psychological Medicine,
Vol. 39,
Issue. 4,
p.
615.
Kipper, Letícia
Wachleski, Cláudia
Salum, Giovanni Abrahão
Heldt, Elizeth
Blaya, Carolina
and
Manfro, Gisele Gus
2009.
Can psychopharmacological treatment change personality traits in patients with panic disorder?.
Revista Brasileira de Psiquiatria,
Vol. 31,
Issue. 4,
p.
307.
Zhao, Li
Zhen, Chen
Wu, Zhaoqiu
Hu, Rong
Zhou, Changlin
and
Guo, Qinglong
2010.
General pharmacological properties, developmental toxicity, and analgesic activity of gambogic acid, a novel natural anticancer agent.
Drug and Chemical Toxicology,
Vol. 33,
Issue. 1,
p.
88.
Dell'Osso, Bernardo
Buoli, Massimiliano
Baldwin, David S.
and
Altamura, A. Carlo
2010.
Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy.
Human Psychopharmacology: Clinical and Experimental,
Vol. 25,
Issue. 1,
p.
17.
Huang, Mei-Feng
Yen, Cheng-Fang
and
Lung, For-Wey
2010.
Moderators and mediators among panic, agoraphobia symptoms, and suicidal ideation in patients with panic disorder.
Comprehensive Psychiatry,
Vol. 51,
Issue. 3,
p.
243.
Tilli, Virpi
Suominen, Kirsi
and
Karlsson, Hasse
2012.
Panic disorder in primary care: Comorbid psychiatric disorders and their persistence.
Scandinavian Journal of Primary Health Care,
Vol. 30,
Issue. 4,
p.
247.
Comments
No Comments have been published for this article.